Close Menu
    Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Biosecurity

    Potential Risks and Benefits of Gain-of-Function Research

    By Global Biodefense StaffApril 15, 2015
    Swine Flu H1N1 Pandemic Analysis
    Credit: Shutterstock, modified by Global Biodefense
    Share
    Facebook LinkedIn Reddit Email

    The National Academies Press has published Potential Risks and Benefits of Gain-of-Function Research, a summary of a two-day public symposia on GOF research convened in December 2014 by the Institute of Medicine and the National Research Council.

    Spurred by incidents at U.S. government laboratories that raised serious biosafety concerns, the U.S. government in Oct. 2014 launched a one-year deliberative process to address the continuing controversy surrounding so-called “gain-of-function” (GOF) research on respiratory pathogens with pandemic potential.

    The gain of function controversy began in late 2011 with the question of whether to publish the results of two experiments involving H5N1 avian influenza and continued to focus on certain research with highly pathogenic avian influenza over the next three years.

    The heart of the U.S. process is an evaluation of the potential risks and benefits of certain types of GOF experiments with influenza, SARS, and MERS viruses that would inform the development and adoption of a new U.S. Government policy governing the funding and conduct of GOF research.

    The main focus of the symposia was to examine and discuss the underlying scientific and technical questions that are the source of current discussion and debate over GOF research involving pathogens with pandemic potential.

    Read the workshop summary online at NAP: Potential Risks and Benefits of Gain-of-Function Research.

    Avian Influenza Biosafety Dual Use Research of Concern (DURC) Emerging Threats H1N1 Influenza
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleUnearthing New Antivirals
    Next Article Disaster Response Coordination to Support Health Outcomes

    Related Stories

    Valley Fever: An Invisible Killer Expands Its Range in the American West

    November 17, 2023

    Virginia Tech Lab Selected for National Partnership to Fight Emerging Diseases

    November 14, 2023

    APHIS Announces Funding for Tribes to Support Animal Disease Preparedness and Response

    October 24, 2023

    Pandemic Flu Has Many Potential Pathways

    October 19, 2023
    News Scan

    Biodefense Headlines – 30 November 2023

    News Scan November 30, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include the largest ever outbreak of mpox in the DRC; launch of National Wastewater Surveillance Program dashboard; low uptake of COVID-19 boosters and flu vaccines;…

    Upcoming Events

    Mar 12
    Hybrid Hybrid Event
    March 12, 2024 - March 17, 2024

    2024 Fungal Genetics Conference

    Mar 21
    March 21, 2024 - March 23, 2024

    ASPPH 2024 Annual Meeting

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    News on pathogens and preparedness for public health emergencies

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.